FDA approves new type of therapy to treat advanced urothelial cancer

FDA granted accelerated approval to Padcev, indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer

Read the full article here

Related Articles


DENGVAXIA For the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. DENGVAXIA is approved for use in individuals 9…